Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Lineage Cell Therapeutics (LCTX.TA) Q3 2024 Earnings
LCTX.TA
8
Aug
Confirmed
Q4 2023
Q2 2024
Q3 2024
-17.04
-11.37
-5.7
-0.03
Details
Expected EPS
-17.042489999999997
Actual EPS
-11.361659999999999
Surprise EPS
5.68
Surprise Percent
+33.33%
Description
Lineage Cell Therapeutics (LCTX.TA) has reported earnings of -11.361659999999999 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login